Chronopin: upcoming release dates, events and other important dates

The $4 billion rebuild of the Mirage, crowned by a 660-foot guitar-shaped hotel tower where the volcano stood, is due to open in the fourth quarter of 2027, later than the early-2027 opening first announced.

Oracle expects The Barn, its 1 GW-plus Stargate campus in Saline Township, Michigan, to start delivering capacity to OpenAI in the second half of 2027.

Flight tests of the UK’s crewed sixth-generation demonstrator are due to start from early 2028, after power-on in mid-2027. More than 11,500 parts – about 90% of the aircraft’s weight – have been designed and released, with final assembly under way in Lancashire.

The Congestion Relief Zone's peak toll for cars with E-ZPass rises from $9 to $12 ($3 overnight) as the MTA's phase-in moves to 80% of the originally approved rates, where it stays through 2030.

Greatest eclipse falls at 15:07:46 UT on 2028-01-26, where the annular phase lasts 10 minutes 27 seconds on a path 323.0 km wide; the longest annularity anywhere on the track is 10m30.6s. The path of annularity crosses Ecuador, Peru, Brazil, Suriname, Spain and Portugal, and a partial eclipse is visible from eastern North America, C. & South America, western Europe and northwestern Africa.

The NFL championship game for the 2027 season is played at Mercedes-Benz Stadium in Atlanta, the city's fourth Super Bowl and the second at this venue after Super Bowl LIII in 2019. CBS has the national broadcast.

Novo Nordisk's phase 3 trial of Cagrisema in obesity reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 2,500 participants. This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive either CagriSema or semaglutide, and which treatment participants receive is decided by chance. CagriSema is a new study medicine being tested, while semaglutide is a medicine that doctors can already prescribe.

Sanofi's phase 3 trial of MenQuadfi in meningococcal infection reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 4,568 participants. The purpose of this study is to describe the safety and immunogenicity of MenACYW conjugate vaccine compared with locally-licensed meningococcal vaccines in healthy infants and toddlers in China. Study details include: * Study duration (including 6-month safety follow-up after the last dose): * Cohort I (Groups 1 and 2): approximately 211 or 271 days (approximately 7 or 9 months) * Cohort II (Groups 3 and 4): up to 18 months * Cohort III (Groups 5 and 6): up to 21 months * Cohort III (Group 7): approximately 16 months * Vaccination Visits Period: * Cohort I (Groups 1 and 2): a 2-dose vaccination at V01 (D01) and V02 (D31) or V03 (D91). Two blood samples are collected pre-vaccination (D01) and 30 days post the 2nd dose of vaccination (D61 or D121).

After more than 80 years of proposals, Bogotá's first metro line, an elevated 24km driverless railway, is targeted to carry its first passengers in 2028.

The 385 m, 62-storey centrepiece of the Tokyo Torch district beside Tokyo Station holds offices, more than 100 shops, an events hall for 2,000 people and the first luxury rental flats in the Otemachi-Marunouchi-Yurakucho district. Construction started in September 2023.

EU member states must have mandatory extended-producer-responsibility schemes for textiles and footwear running by 16 April 2028, 30 months after the revised Waste Framework Directive entered into force. The schemes make clothing and footwear makers fund the collection, sorting and recycling of textile waste.

The UAW's contracts with General Motors, Ford and Stellantis run out on 30 April 2028 - a date the union chose so members could strike on May Day.

A 700,000-square-foot building joined to the George R. Brown Convention Center, holding two exhibition halls, an atrium hall and the largest ballroom in Texas, plus a 100,000-square-foot pedestrian plaza linking it to the Toyota Center. Houston First financed this first phase of its $2 billion convention district transformation with about $1.38 billion of hotel occupancy tax and special revenue bonds.

Boehringer Ingelheim's phase 3 trial of Vicadrostat in heart failure reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 6,000 participants. This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Participants are put into 2 groups by chance. Every participant has an equal chance of being in each group. The groups are: * Vicadrostat/empagliflozin group: participants take vicadrostat/empagliflozin as tablets once a day. * Placebo/empagliflozin group: participants take placebo/empagliflozin as tablets once a day. Participants can stay in the study as long as they benefit from treatment and can tolerate it. During this time, they visit their doctors regularly. The doctors regularly check participants' health and take note of any unwanted effects.